New Inroads Against Multiple Sclerosis

JAMA. 2018 Jan 2;319(1):9-11. doi: 10.1001/jama.2017.14033.
No abstract available

Publication types

  • Interview
  • News

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Disease Progression
  • Drug Discovery
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Male
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / physiopathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • ocrelizumab